(Q44280462)

1 December 2017

title

Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group (English)

1 reference

1 December 2017

1 reference

1 reference

Zarski JP

1

1 reference

1 December 2017

Marcellin P

2

1 reference

1 December 2017

Cohard M

3

1 reference

1 December 2017

Lutz JM

4

1 reference

1 December 2017

Bouche C

5

1 reference

1 December 2017

Rais A

6

1 reference

1 December 2017

language of work or name

1 reference

1 May 1994

1 reference

1 December 2017

published in

Journal of Hepatology

1 reference

1 December 2017

volume

20

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

636-640

1 reference

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Hepatitis B virus DNA (HBV-DNA) in anti-HBe positive sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum. Analysis of 1063 specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

Symptomatic anti-HBe positive chronic hepatitis B in taiwan with special reference to persistent HBV replication and HDV superinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980352-6

7 January 2021

10.1016/S0168-8278(05)80352-6

Identifiers

DOI

1 reference

1 December 2017

1 reference